Bicoll and Naturalpha announce Nutraceutical Research Alliance

European-Funded research Cooperation Olnorme II extended

22-Jul-2011 - Bicoll GmbH and Naturalpha announced that they initiated a research alliance. Their joint project will focus on the development of innovative and qualified botanical ingredients for food and nutraceutical applications aiming to prevent disorders that contain an inflammatory component. Chronic low ...

Bicoll and the European Molecular Biology Laboratory (EMBL) identify aurora kinase inhibitors

24-Jun-2010 - BICOLL GmbH and EMBL announced the successful completion of a joint research project on the identification of active compounds as inhibitors of aurora kinases. Aurora kinases have gained a great deal of attention as possible anticancer drug targets as these serine/threonine kinases are ...

Bicoll Biotechnology (Shanghai) Co. Ltd. completes modernization of its laboratory facilities for medicinal chemistry

09-Oct-2009 - Bicoll Biotechnology (Shanghai) Co. Ltd., announced that it has completed the modernization of its laboratory facilities for medicinal chemistry within Zhangjiang Hi-Tech Park, Shanghai to meet increasing demand for its medicinal chemistry capacities. At its central laboratory facility in ...

Bicoll (Shanghai) Co. Ltd. expands its laboratory facilities within Zhangjiang Hi-Tech Park/Shanghai

31-Oct-2006 - Bicoll Biotechnology (Shanghai) Co. Ltd., announced that it has expanded its laboratory facilities for R&D drug discovery and development within the Zhangjiang Hi-Tech Park, Shanghai. Now nearly the double size of lab space is at Bicoll's disposal. Especially Bicoll's custom synthesis unit will ...